Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP380025.RAXeP16Y6IKzdROfKWnUrAjvR2YzUxZe0yjlg35F4_2vc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP380025.RAXeP16Y6IKzdROfKWnUrAjvR2YzUxZe0yjlg35F4_2vc130_assertion type Assertion NP380025.RAXeP16Y6IKzdROfKWnUrAjvR2YzUxZe0yjlg35F4_2vc130_head.
- NP380025.RAXeP16Y6IKzdROfKWnUrAjvR2YzUxZe0yjlg35F4_2vc130_assertion description "[Assessing HER2 gene amplification as a potential target for therapy in invasive urothelial bladder cancer with a standardized methodology: results in 1005 patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP380025.RAXeP16Y6IKzdROfKWnUrAjvR2YzUxZe0yjlg35F4_2vc130_provenance.
- NP380025.RAXeP16Y6IKzdROfKWnUrAjvR2YzUxZe0yjlg35F4_2vc130_assertion evidence source_evidence_literature NP380025.RAXeP16Y6IKzdROfKWnUrAjvR2YzUxZe0yjlg35F4_2vc130_provenance.
- NP380025.RAXeP16Y6IKzdROfKWnUrAjvR2YzUxZe0yjlg35F4_2vc130_assertion SIO_000772 19889613 NP380025.RAXeP16Y6IKzdROfKWnUrAjvR2YzUxZe0yjlg35F4_2vc130_provenance.
- NP380025.RAXeP16Y6IKzdROfKWnUrAjvR2YzUxZe0yjlg35F4_2vc130_assertion wasDerivedFrom befree-20150227 NP380025.RAXeP16Y6IKzdROfKWnUrAjvR2YzUxZe0yjlg35F4_2vc130_provenance.
- NP380025.RAXeP16Y6IKzdROfKWnUrAjvR2YzUxZe0yjlg35F4_2vc130_assertion wasGeneratedBy ECO_0000203 NP380025.RAXeP16Y6IKzdROfKWnUrAjvR2YzUxZe0yjlg35F4_2vc130_provenance.